CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve the understanding of immune-related adverse events in cancer patients undergoing immunotherapy. By using patient-reported outcomes, it seeks to develop specific tools to better capture patients' experiences and correlate symptoms with immune biomarkers.
Immuno-oncology (IO) and specifically immune checkpoint inhibitors (ICIs) have recently shown significant clinical benefit in a growing number of different tumor types.
However 60-90% of the patients experience immune-related adverse events (irAEs) associated with inflammatory or autoimmune responses that can affect any organ and system.
Early recognition and treatment of these irAEs is crucial to reduce morbidity, organ complications and ultimately, mortality.
Patient reported outcomes (PROs) r…
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
